102 related articles for article (PubMed ID: 11965497)
1. Death effector domain-containing proteins DEDD and FLAME-3 form nuclear complexes with the TFIIIC102 subunit of human transcription factor IIIC.
Zhan Y; Hegde R; Srinivasula SM; Fernandes-Alnemri T; Alnemri ES
Cell Death Differ; 2002 Apr; 9(4):439-47. PubMed ID: 11965497
[TBL] [Abstract][Full Text] [Related]
2. Nuclear localization of DEDD leads to caspase-6 activation through its death effector domain and inhibition of RNA polymerase I dependent transcription.
Schickling O; Stegh AH; Byrd J; Peter ME
Cell Death Differ; 2001 Dec; 8(12):1157-68. PubMed ID: 11753564
[TBL] [Abstract][Full Text] [Related]
3. DEDD and DEDD2 associate with caspase-8/10 and signal cell death.
Alcivar A; Hu S; Tang J; Yang X
Oncogene; 2003 Jan; 22(2):291-7. PubMed ID: 12527898
[TBL] [Abstract][Full Text] [Related]
4. DEDD, a novel death effector domain-containing protein, targeted to the nucleolus.
Stegh AH; Schickling O; Ehret A; Scaffidi C; Peterhänsel C; Hofmann TG; Grummt I; Krammer PH; Peter ME
EMBO J; 1998 Oct; 17(20):5974-86. PubMed ID: 9774341
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of DEDD2, a death effector domain-containing protein.
Roth W; Stenner-Liewen F; Pawlowski K; Godzik A; Reed JC
J Biol Chem; 2002 Mar; 277(9):7501-8. PubMed ID: 11741985
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of DEDDL, a human-specific isoform of DEDD.
Huang X; Zhang M; Tang H; Ruo C; Cao X
Gene Expr; 2006; 13(3):141-53. PubMed ID: 17193921
[TBL] [Abstract][Full Text] [Related]
7. The death effector domain-associated factor plays distinct regulatory roles in the nucleus and cytoplasm.
Zheng L; Schickling O; Peter ME; Lenardo MJ
J Biol Chem; 2001 Aug; 276(34):31945-52. PubMed ID: 11395500
[TBL] [Abstract][Full Text] [Related]
8. DEDD regulates degradation of intermediate filaments during apoptosis.
Lee JC; Schickling O; Stegh AH; Oshima RG; Dinsdale D; Cohen GM; Peter ME
J Cell Biol; 2002 Sep; 158(6):1051-66. PubMed ID: 12235123
[TBL] [Abstract][Full Text] [Related]
9. Influenza A virus matrix protein 1 interacts with hTFIIIC102-s, a short isoform of the polypeptide 3 subunit of human general transcription factor IIIC.
Huang S; Chen J; Wang H; Sun B; Wang H; Zhang Z; Zhang X; Chen Z
Arch Virol; 2009; 154(7):1101-10. PubMed ID: 19521658
[TBL] [Abstract][Full Text] [Related]
10. Cloning and characterization of two evolutionarily conserved subunits (TFIIIC102 and TFIIIC63) of human TFIIIC and their involvement in functional interactions with TFIIIB and RNA polymerase III.
Hsieh YJ; Wang Z; Kovelman R; Roeder RG
Mol Cell Biol; 1999 Jul; 19(7):4944-52. PubMed ID: 10373544
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel inhibitor of nuclear factor-kappaB, RelA-associated inhibitor.
Yang JP; Hori M; Sanda T; Okamoto T
J Biol Chem; 1999 May; 274(22):15662-70. PubMed ID: 10336463
[TBL] [Abstract][Full Text] [Related]
12. The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN.
Heyninck K; De Valck D; Vanden Berghe W; Van Criekinge W; Contreras R; Fiers W; Haegeman G; Beyaert R
J Cell Biol; 1999 Jun; 145(7):1471-82. PubMed ID: 10385526
[TBL] [Abstract][Full Text] [Related]
13. NF-AT-Driven interleukin-4 transcription potentiated by NIP45.
Hodge MR; Chun HJ; Rengarajan J; Alt A; Lieberson R; Glimcher LH
Science; 1996 Dec; 274(5294):1903-5. PubMed ID: 8943202
[TBL] [Abstract][Full Text] [Related]
14. The death effector domain protein family: regulators of cellular homeostasis.
Tibbetts MD; Zheng L; Lenardo MJ
Nat Immunol; 2003 May; 4(5):404-9. PubMed ID: 12719729
[TBL] [Abstract][Full Text] [Related]
15. Heterotypic interactions among NACHT domains: implications for regulation of innate immune responses.
Damiano JS; Oliveira V; Welsh K; Reed JC
Biochem J; 2004 Jul; 381(Pt 1):213-9. PubMed ID: 15107016
[TBL] [Abstract][Full Text] [Related]
16. I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding.
Ganchi PA; Sun SC; Greene WC; Ballard DW
Mol Biol Cell; 1992 Dec; 3(12):1339-52. PubMed ID: 1493333
[TBL] [Abstract][Full Text] [Related]
17. Death-effector domain-containing protein DEDD is an inhibitor of mitotic Cdk1/cyclin B1.
Arai S; Miyake K; Voit R; Nemoto S; Wakeland EK; Grummt I; Miyazaki T
Proc Natl Acad Sci U S A; 2007 Feb; 104(7):2289-94. PubMed ID: 17283331
[TBL] [Abstract][Full Text] [Related]
18. Death effector domain DEDa, a self-cleaved product of caspase-8/Mch5, translocates to the nucleus by binding to ERK1/2 and upregulates procaspase-8 expression via a p53-dependent mechanism.
Yao Z; Duan S; Hou D; Heese K; Wu M
EMBO J; 2007 Feb; 26(4):1068-80. PubMed ID: 17290218
[TBL] [Abstract][Full Text] [Related]
19. Low DEDD expression in breast cancer cells indicates higher sensitivity to the Bcl-2-specific inhibitor ABT-199.
Liu D; Qin X; Sun Z; Hou S; Lv Q
Biochem Biophys Res Commun; 2020 May; 525(3):549-556. PubMed ID: 32113682
[TBL] [Abstract][Full Text] [Related]
20. The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT.
Huynh KD; Bardwell VJ
Oncogene; 1998 Nov; 17(19):2473-84. PubMed ID: 9824158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
